The Lung Cancer Policy Network has published 2024 year in review: from evidence to action, showcasing the progress we’ve made in the past year.
Our primary goal was to turn our extensive evidence on reducing lung cancer mortality – which we’ve been gathering since 2021 – into actionable policy change.
Over the past year, the Network has grown to over 80 members from 34 countries, and we have strengthened our role as a trusted voice in the lung cancer space. Our growing community has been instrumental in shaping evidence-based, consensus-driven outputs that reflect the realities of lung cancer care around the world.
Looking ahead to 2025, we are focused on extending our global reach, and leveraging our collective expertise and respected position to further advance early detection, improve lung cancer care, and drive meaningful policy impact.
We hope you will join us.
Recent news
News
Turning lung cancer policy into action at WCLC 2026
At this year’s World Conference on Lung Cancer (WCLC), the Network will host two sessions designed bridge this gap: one focused on the skills needed to influence policy, and the other on the financing and delivery of lung cancer priorities in practice.
News
Delays in lung cancer care addressed in new policy brief on timed targets
Timed targets set time frames for diagnosis, treatment and other aspects of care, and are a practical way to improve outcomes and accountability.
Case study
A radiology-led model for LDCT in Norway: the first pilot programme
Norway’s pilot programme stands out for its radiology-led model, which substantially reduced the workload for respiratory services.